维亚生物科技控股集团（股票代码：01873）于2026年6月12日发布公告，披露当日于香港联交所场内回购普通股40万股，占其已发行股本约0.0188%。本次回购每股价格为1.20港元，合计涉资约48万港元。
公告显示，回购后公司已发行股本依旧维持在2,129,882,353股。公司于2025年6月12日获股东大会通过回购授权，授权数量为212,843,430股，截至目前已累计回购28,093,000股，占授权通过当日已发行股本的1.3199%。
公司确认此次回购已遵守香港联交所上市规则及相关法律规定，所回购股份尚待注销。公告由执行董事毛晨签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.